Recent advances in mucosal vaccines and adjuvants.

[1]  R. Ulrich,et al.  Mucosal Tolerance to a Bacterial Superantigen Indicates a Novel Pathway To Prevent Toxic Shock , 2002, Infection and Immunity.

[2]  M. Saijo,et al.  Chimeric recombinant hepatitis E virus-like particles as an oral vaccine vehicle presenting foreign epitopes. , 2002, Virology.

[3]  E. Sandström,et al.  DNA mucosal HIV vaccine in humans. , 2001, Virus research.

[4]  C. Greer,et al.  Human immunodeficiency virus type 1 Gag-specific vaginal immunity and protection after local immunizations with sindbis virus-based replicon particles. , 2001, The Journal of infectious diseases.

[5]  Todd M. Allen,et al.  Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques , 2001, Nature Medicine.

[6]  J. Holmgren,et al.  Nasal and Vaginal Vaccinations Have Differential Effects on Antibody Responses in Vaginal and Cervical Secretions in Humans , 2001, Infection and Immunity.

[7]  M. Singh,et al.  Mucosal immunization with HIV-1 gag DNA on cationic microparticles prolongs gene expression and enhances local and systemic immunity. , 2001, Vaccine.

[8]  L. Qiao,et al.  Papillomavirus Pseudovirus: a Novel Vaccine To Induce Mucosal and Systemic Cytotoxic T-Lymphocyte Responses , 2001, Journal of Virology.

[9]  H. Liao,et al.  Cytokine Requirements for Induction of Systemic and Mucosal CTL After Nasal Immunization1 , 2001, The Journal of Immunology.

[10]  N. Mielcarek,et al.  Nasal Administration of Schistosoma mansoni Egg Antigen‐Cholera B Subunit Conjugate Suppresses Hepatic Granuloma Formation and Reduces Mortality in S. mansoni‐Infected Mice , 2001, Scandinavian journal of immunology.

[11]  M. Estes,et al.  Recombinant Norwalk Virus-Like Particles Administered Intranasally to Mice Induce Systemic and Mucosal (Fecal and Vaginal) Immune Responses , 2001, Journal of Virology.

[12]  C. Stokes,et al.  Targeted lymph node immunization can protect cats from a mucosal challenge with feline immunodeficiency virus. , 2001, Vaccine.

[13]  J. Bonnefoy,et al.  Targeting of Nasal Mucosa-Associated Antigen-Presenting Cells In Vivo with an Outer Membrane Protein A Derived from Klebsiellapneumoniae , 2001, Infection and Immunity.

[14]  K. Schön,et al.  CTA1-DD-Immune Stimulating Complexes: a Novel, Rationally Designed Combined Mucosal Vaccine Adjuvant Effective with Nanogram Doses of Antigen1 , 2001, The Journal of Immunology.

[15]  B. Rouse,et al.  Immunopotentiation of DNA vaccine against herpes simplex virus via co-delivery of plasmid DNA expressing CCR7 ligands. , 2001, Vaccine.

[16]  G. Kingsley,et al.  Control of rheumatoid arthritis by oral tolerance. , 2001, Arthritis and rheumatism.

[17]  Y. Oh,et al.  Nasal absorption and biodistribution of plasmid DNA: an alternative route of DNA vaccine delivery. , 2001, Vaccine.

[18]  N. Walters,et al.  M cell-targeted DNA vaccination , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  T. Miyamura,et al.  Oral administration of hepatitis E virus-like particles induces a systemic and mucosal immune response in mice. , 2001, Vaccine.

[20]  J. Wilschut,et al.  Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity. , 2001, Vaccine.

[21]  G. Dougan,et al.  Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants. , 2001, Vaccine.

[22]  W. Strober,et al.  Oral Administration of Recombinant Cholera Toxin Subunit B Inhibits IL-12-Mediated Murine Experimental (Trinitrobenzene Sulfonic Acid) Colitis1 , 2001, The Journal of Immunology.

[23]  H. Müller-Alouf,et al.  Mucosal Immune Responses and Protection against Tetanus Toxin after Intranasal Immunization with RecombinantLactobacillus plantarum , 2001, Infection and Immunity.

[24]  K. Rosenthal,et al.  Intranasal Immunization with CpG Oligodeoxynucleotides as an Adjuvant Dramatically Increases IgA and Protection Against Herpes Simplex Virus-2 in the Genital Tract1 , 2001, The Journal of Immunology.

[25]  K. Komase,et al.  Effectiveness and safety of mutant Escherichia coli heat-labile enterotoxin (LT H44A) as an adjuvant for nasal influenza vaccine. , 2001, Vaccine.

[26]  B. Schwartz,et al.  Intussusception among infants given an oral rotavirus vaccine. , 2001, The New England journal of medicine.

[27]  Gerhard Walzl,et al.  Mucosal Delivery of a Respiratory Syncytial Virus CTL Peptide with Enterotoxin-Based Adjuvants Elicits Protective, Immunopathogenic, and Immunoregulatory Antiviral CD8+ T Cell Responses1 , 2001, The Journal of Immunology.

[28]  D. Taub,et al.  RANTES Potentiates Antigen-Specific Mucosal Immune Responses1 , 2001, The Journal of Immunology.

[29]  D. Driver,et al.  Infection of Human Dendritic Cells by a Sindbis Virus Replicon Vector Is Determined by a Single Amino Acid Substitution in the E2 Glycoprotein , 2000, Journal of Virology.

[30]  J. Igietseme,et al.  Induction of Protective Immunity against Chlamydia trachomatis Genital Infection by a Vaccine Based on Major Outer Membrane Protein–Lipophilic Immune Response-Stimulating Complexes , 2000, Infection and Immunity.

[31]  J. Berzofsky,et al.  Interplay of Cytokines and Adjuvants in the Regulation of Mucosal and Systemic HIV-Specific CTL , 2000, The Journal of Immunology.

[32]  A. Krieg,et al.  CpG DNA is an effective oral adjuvant to protein antigens in mice. , 2000, Vaccine.

[33]  D. Montefiori,et al.  Effective Induction of Simian Immunodeficiency Virus-Specific Systemic and Mucosal Immune Responses in Primates by Vaccination with Proviral DNA Producing Intact but Noninfectious Virions , 2000, Journal of Virology.

[34]  J. Mcghee,et al.  Cutting Edge: The Mucosal Adjuvant Cholera Toxin Redirects Vaccine Proteins into Olfactory Tissues , 2000, The Journal of Immunology.

[35]  C. Czerkinsky,et al.  Oral administration of cholera toxin B subunit conjugated to myelin basic protein protects against experimental autoimmune encephalomyelitis by inducing transforming growth factor-beta-secreting cells and suppressing chemokine expression. , 2000, International immunology.

[36]  L. Babiuk,et al.  Gene Gun-Mediated DNA Immunization Primes Development of Mucosal Immunity against Bovine Herpesvirus 1 in Cattle , 2000, Journal of Virology.